Innovite has developed a novel process for impregnating a matrix (vegetable source) with active ingredients. This material is then compressed into tablets having uniform, continuous release rates. This proprietary process uses a cold-extrusion technique that extends stability profiles by eliminating heat, moisture and solvents. The manufacturing process - from receipt of raw materials to shipment of the finished dosage form - is consistent with Current Good Manufacturing Practice (cGMP).